Share Prices & Company Research

Stockbroking

AstraZeneca

Current Price 5973.00p Bid 5971.00p Ask 5973.00p Change -0.12%
Last Updated: 21/08/2018 15:05. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Financial Highlights Year Ended 31/12/2017

Turnover
£22,465.00m
Operating Profit
£3,677.00m
Dividend Yield
3.41
Dividend Per Share
202.50
Dividend Cover
1.17
P/E Ratio
25.02

Key Personnel

Pascal Claude Roland Soriot
Chief Executive Officer
Marc Pierre Jean Dunoyer
Chief Financial Officer
Leif Valdemar Johansson
Non-Executive Chairman
Baroness Shriti Vadera
Non-Executive Director
Marcus Wallenberg
Non-Executive Director
Rudolph Harold Peter Markham
Non-Executive Director
Prof Sabera Nazneen Rahman
Non-Executive Director
Sherilyn Dawn McCoy
Non-Executive Director
Deborah DiSanzo
Non-Executive Director
Graham Andrew Chipchase
Non-Executive Director
Philip Arthur John Broadley
Non-Executive Director
Prof Geneviève Bernadette Berger
Non-Executive Director

Stock Details

EPIC
AZN
ISIN
GB0009895292
Shares in Issue
1,266,776,325
Market cap
£75,119.84m

Analyst Views (10)

Strong Buy
 
50.00%
Buy
 
20.00%
Hold
 
30.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
5972.00p
Bid Price
5971.00p
Ask Price
5973.00p
Volume
511537
Change Today
-7.00p
% Change Today
-0.12%
Open
5980.00p
Previous Close
5979.00p
Intraday High
6008.00p
Intraday Low
5970.50p
52 Week High
6122.00p
52 Week Low
4380.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

AstraZeneca Intra-day Chart

AstraZeneca News

News in this section is provided by MoneyAM

AstraZeneca lung cancer treatment gets regulatory nod in Japan 21 Aug 2018 | 07:46 AstraZeneca prices $3bn bond offering 15 Aug 2018 | 08:39 AstraZeneca neurofibromatosis treatment granted orphan status in EU 03 Aug 2018 | 08:30 Broker Forecast - UBS issues a broker note on AstraZeneca PLC 30 Jul 2018 | 11:10 AstraZeneca gets Europe nod for lung cancer treatment 27 Jul 2018 | 15:06 FTSE fails to take advantage of weaker sterling 26 Jul 2018 | 17:04 FTSE flat as impact of Shell offsets Super Thursday 26 Jul 2018 | 12:11 Weakness in mining and oil sectors fail to hold FTSE back 26 Jul 2018 | 09:01 AstraZeneca Q2 net profit down but new drugs help boost sales 26 Jul 2018 | 07:56 AstraZeneca sells European rights for heart failure treatment for $210m 24 Jul 2018 | 09:13 UK stocks edge higher on positive earnings, China stimulus hopes 24 Jul 2018 | 09:05 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 20 Jul 2018 | 09:20 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 17 Jul 2018 | 09:20 Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC 13 Jul 2018 | 09:20 Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC 10 Jul 2018 | 10:30 UK stocks open 1.0% lower as trade tensions brew 02 Jul 2018 | 09:05 AstraZeneca, Merck breast cancer treatment gets Japanese nod 02 Jul 2018 | 07:42 AstraZeneca's lung cancer treatment receives approval in Japan 02 Jul 2018 | 07:29 AstraZeneca gets European nod for pen-device diabetes treatment 29 Jun 2018 | 15:10 UK stocks open 0.1% lower as trade tensions simmer 27 Jun 2018 | 09:04 AstraZeneca ovarian cancer drug meets primary objective 27 Jun 2018 | 07:55 Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC 20 Jun 2018 | 08:40 Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC 15 Jun 2018 | 10:20 UK stocks open 0.1% lower as key Brexit votes loom 12 Jun 2018 | 08:57 AstraZeneca, Eli Lilly end phase III clinical trials of Alzheimer drug 12 Jun 2018 | 07:25 FTSE rises on higher oil prices 30 May 2018 | 16:42 Weaker miners fail to hold back FTSE 30 May 2018 | 11:22 Broker Forecast - Shore Capital issues a broker note on AstraZeneca PLC 30 May 2018 | 09:00 AstraZeneca's severe asthma drug fails to meet primary objective in second clinical trial 30 May 2018 | 07:19 FTSE closes up after seesaw afternoon 25 May 2018 | 16:38

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
7,615.0
6,848.0
Intangible Assets & Goodwill
38,013.0
39,244.0
Investments & Other Non-Current Assets
4,576.0
3,172.0
Total Non-Current Assets
50,204.0
49,264.0
Inventory
3,035.0
2,334.0
Trade & Receivables
5,009.0
4,573.0
Cash & Receivables
3,324.0
5,018.0
Other Current Assets & Assets Held for Resale
1,782.0
1,337.0
Total Assets
63,354.0
62,526.0

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
16,383.0
15,256.0
Long Term Liabilities
30,329.0
30,601.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
46,712.0
45,857.0

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
16,642.0
16,669.0

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
317.0
316.0
Minority Interests
1,682.0
1,815.0
Retained Earnings
8,221.0
8,140.0
Share Premium Account
4,393.0
4,351.0
Other Equity
2,029.0
2,047.0
Total Equity
16,642.0
16,669.0

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
3,578.0
4,145.0
Cashflow Before Financing
1,250.0
176.0
Increase / Decrease in Cash
-1,686.0
-1,148.0

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
22,465.0
23,002.0
Cost of Sales
4,318.0
4,126.0
Gross Profit
18,147.0
18,876.0
Operating Profit
3,677.0
4,902.0
Pre-Tax Profit
2,227.0
3,552.0
Profit / Loss for the Year
2,868.0
3,406.0

Dividend History

Data has been provided by MoneyAM

Period
Ex-Dividend Date
Payment Date
H1 Dividend
09 Aug 2018
10 Sep 2018
H2 Dividend
15 Feb 2018
19 Mar 2018
H1 Dividend
10 Aug 2017
11 Sep 2017
H2 Dividend
16 Feb 2017
20 Mar 2017
H1 Dividend
11 Aug 2016
12 Sep 2016
H2 Dividend
18 Feb 2016
21 Mar 2016
H1 Dividend
13 Aug 2015
14 Sep 2015
H2 Dividend
19 Feb 2015
23 Mar 2015
H1 Dividend
13 Aug 2014
15 Sep 2014
H2 Dividend
19 Feb 2014
24 Mar 2014
H1 Dividend
14 Aug 2013
16 Sep 2013
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.